Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms

N Engl J Med. 2012 Jul 19;367(3):248-57. doi: 10.1056/NEJMcp1106637.
No abstract available

Publication types

  • Review

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use
  • Adrenergic alpha-Antagonists / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Lower Urinary Tract Symptoms / drug therapy*
  • Lower Urinary Tract Symptoms / etiology
  • Male
  • Middle Aged
  • Muscarinic Antagonists / therapeutic use
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Practice Guidelines as Topic
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Hyperplasia / drug therapy*

Substances

  • 5-alpha Reductase Inhibitors
  • Adrenergic alpha-Antagonists
  • Muscarinic Antagonists
  • Phosphodiesterase 5 Inhibitors